Dandelion Science Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Dandelion Science General Information
Description
Developer of neurological therapy designed to offer an alternate way to neuropsychiatric and neurological treatments. The company's therapy offers programmable therapeutics that target the data pathways and have the potential to reimagine brain treatment, enabling medical professionals to effectively treat brain disorders.
Contact Information
Website
www.dandelion.scienceCorporate Office
- 75 State Street
- Suite 100
- Boston, MA 02109
- United States
Corporate Office
- 75 State Street
- Suite 100
- Boston, MA 02109
- United States
Dandelion Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 01-Aug-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-May-2022 | Completed | Generating Revenue | |||
| 1. Grant | 01-Sep-2021 | $374K | Completed | Generating Revenue |
Dandelion Science Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Dandelion Science Patents
Dandelion Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4819910-A1 | Method and system for tagging visual features in video material and neuroimaging recovery of visual evoked potentials | Pending | 07-Dec-2023 | ||
| WO-2025122906-A1 | Method and system for tagging visual features in video material and neuroimaging recovery of visual evoked potentials | Inactive | 07-Dec-2023 | ||
| EP-4805957-A1 | Systems and methods of generative neurostimulation and neuromodulation for treatment of disease | Pending | 06-Nov-2023 | ||
| WO-2025101626-A1 | Systems and methods of generative neurostimulation and neuromodulation for treatment of disease | Inactive | 06-Nov-2023 | ||
| EP-4710341-A1 | Systems and methods to process generative or dynamic video and images to target healthy neural pathways | Pending | 10-May-2023 | G16H20/30 |
Dandelion Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dandelion Science Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boro Capital | Venture Capital | Minority | ||
| Monday Capital | Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| U.S. Department of Health and Human Services | Government |
Dandelion Science FAQs
-
When was Dandelion Science founded?
Dandelion Science was founded in 2020.
-
Where is Dandelion Science headquartered?
Dandelion Science is headquartered in Boston, MA.
-
What is the size of Dandelion Science?
Dandelion Science has 13 total employees.
-
What industry is Dandelion Science in?
Dandelion Science’s primary industry is Decision/Risk Analysis.
-
Is Dandelion Science a private or public company?
Dandelion Science is a Private company.
-
What is Dandelion Science’s current revenue?
The current revenue for Dandelion Science is .
-
Who are Dandelion Science’s investors?
Boro Capital, Monday Capital, National Institutes of Health, and U.S. Department of Health and Human Services have invested in Dandelion Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
